E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/1/2016 in the Prospect News Investment Grade Daily.

New Issue: Pfizer details sale of $5 billion notes in five tranches

By Lisa Kerner

Charlotte, N.C., June 1 – Pfizer Inc. priced $5 billion of notes (A1/AA/A+) in five parts, according to an FWP filed with the Securities and Exchange Commission.

The company sold $1.25 billion of 1.2% two-year notes at 99.927 to yield 1.237%. The notes priced at Treasuries plus 35 basis points, on the tight side of guidance of 40 bps, plus or minus 5 bps, over Treasuries.

Pfizer priced $850 million of 1.45% three-year notes 99.886 to yield 1.489%, or 45 bps over Treasuries, compared to talk of Treasuries plus 50 bps, plus or minus 5 bps.

The $1.15 billion tranche of 1.95% five-year notes priced at 99.853 to yield 1.981%, with a spread of 60 bps over Treasuries. The notes were guided at Treasuries plus 65 bps, plus or minus 5 bps.

Pfizer placed $1.25 billion of 2.75% 10-year notes at 90 bps over Treasuries, compared to guidance of 95 bps, plus or minus 5 bps, over Treasuries. The notes priced at 99.974 to yield 2.753%.

In addition, Pfizer priced a $500 million add-on to its 4.4% notes due May 15, 2044 at 110.146 to yield 3.807%. The notes priced at Treasuries plus 115 bps, on the tight side of guidance of 120 bps, plus or minus 5 bps, over Treasuries.

Pfizer originally sold the 4.4% notes due 2044 in a $500 million offering on May 12, 2014 at 95 bps over Treasuries. The total outstanding is $1 billion.

Barclays, Goldman Sachs & Co., J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC were the bookrunners.

Proceeds will be used for general corporate purposes and to repay outstanding commercial paper, according to details from a 424B3 filing with the SEC.

Pfizer is a biopharmaceutical company based in New York.

Issuer:Pfizer Inc.
Amount:$5 billion
Securities:Senior notes
Bookrunners:Barclays, Goldman Sachs & Co., J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC
Passive bookrunners:BofA Merrill Lynch, Credit Suisse Securities (USA) LLC, Deutsche Bank Securities Inc.
Senior co-managers:HSBC Securities (USA) Inc., RBC Capital Markets, LLC
Co-managers:BNP Paribas Securities Corp., Drexel Hamilton, LLC, Lebenthal & Co., Mizuho Securities USA Inc., Siebert Brandford Shank & Co., LLC, Williams Capital Group LP
Pricing date:May 31
Settlement:June 3
Ratings:Moody’s: A1
S&P: AA
Fitch: A+
Distribution:SEC registered
Two-year notes
Amount:$1.25 billion
Maturity:June 1, 2018
Coupon:1.2%
Price:99.927
Yield:1.237%
Spread:Treasuries plus 35 bps
Price guidance:Treasuries plus 40 bps, plus or minus 5 bps
Make-whole call: Treasuries plus 5 bps
Three-year notes
Amount:$850 million
Maturity:June 3, 2019
Coupon:1.45%
Price:99.886
Yield:1.489%
Spread:Treasuries plus 45 bps
Price guidance:Treasuries plus 50 bps, plus or minus 5 bps
Make-whole call: Treasuries plus 7 bps
Five-year notes
Amount:$1.15 billion
Maturity:June 3, 2021
Coupon:1.95%
Price:99.853
Yield:1.981%
Spread:Treasuries plus 60 bps
Price guidance:Treasuries plus 65 bps, plus or minus 5 bps
Make-whole call: Treasuries plus 10 bps
10-year notes
Amount:$1.25 billion
Maturity:June 3, 2026
Coupon:2.75%
Price:99.974
Yield:2.753%
Spread:Treasuries plus 90 bps
Price guidance:Treasuries plus 95 bps, plus or minus 5 bps
Make-whole call: Treasuries plus 15 bps
Add-on notes
Amount:$500 million reopening
Maturity:May 15, 2044
Coupon:4.4%
Price:110.146
Yield:3.807%
Spread:Treasuries plus 115 bps
Price guidance:Treasuries plus 120 bps, plus or minus 5 bps
Make-whole call: Treasuries plus 15 bps
Total outstanding:$1 billion

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.